| Stroke/CHD | All-cause mortality | ||||
---|---|---|---|---|---|---|
Cases/Noncases | Incidence HR (95% CI) | P value | Cases/Noncases | Incidence HR (95% CI) | P value | |
Overall | Â | Â | Â | Â | Â | Â |
 Normal geometry | 336/7603 | Reference | – | 239/7700 | Reference | – |
 Concentric remodeling | 73/686 | 1.42 (1.09, 1.84) | 0.01 | 49/710 | 1.23 (0.89, 1.69) | 0.21 |
 Concentric hypertrophy | 67/359 | 1.39 (1.04, 1.86) | 0.03 | 47/379 | 1.50 (1.07, 2.12) | 0.02 |
 Eccentric hypertrophy | 92/724 | 1.42 (1.11, 1.82) |  < 0.01 | 76/740 | 1.58 (1.19, 2.10) |  < 0.01 |
Male | Â | Â | Â | Â | Â | Â |
 Normal geometry | 183/3634 | Reference | – | 129/3688 | Reference | – |
 Concentric remodeling | 40/289 | 1.39 (0.98, 1.99) | 0.07 | 29/300 | 1.50 (0.99, 2.29) | 0.06 |
 Concentric hypertrophy | 31/144 | 1.27 (0.83, 1.96) | 0.27 | 15/160 | 1.01 (0.56, 1.81) | 0.98 |
 Eccentric hypertrophy | 41/228 | 1.55 (1.08, 2.24) | 0.02 | 29/240 | 1.55 (1.00, 2.41) | 0.05 |
Female | Â | Â | Â | Â | Â | Â |
 Normal geometry | 153/3969 | Reference | – | 110/4012 | Reference | – |
 Concentric remodeling | 33/397 | 1.36 (0.92, 2.01) | 0.12 | 20/410 | 0.94 (0.57, 1.55) | 0.81 |
 Concentric hypertrophy | 36/215 | 1.58 (1.06, 2.36) | 0.03 | 32/219 | 1.99 (1.29, 3.08) |  < 0.01 |
 Eccentric hypertrophy | 51/496 | 1.27 (0.90, 1.79) | 0.18 | 47/500 | 1.68 (1.16, 2.44) |  < 0.01 |